For the study ... show. The findings were published Monday in the Annals of Internal Medicine. There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug ...

Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental ...

A total of 77 suicide deaths in GLP-1 agonist users and 71 in SGLT2 inhibitor users were identified. Subgroup analyses ...

If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...

At least two in five U.S. adults under the age of 65 with "private insurance could be eligible under clinical criteria for GLP-1 drugs," a new KFF analysis shows.

A study has found a higher risk of suicidal thoughts in users of Novo Nordisk's GLP-1 agonist-based drugs ... evidence and with other drugs, for being cautious in the use of semaglutide, and ...

Related Study shows shift in GLP-1 drug use for obesity, not diabetes Weight loss drug Zepbound outperforms Ozempic in new ...

Like its U.S. and European counterparts, Britain’s Medicines and Healthcare Products Regulatory Agency found no conclusive ...

although the latter also appeared to show monomerization of the semaglutide samples similar to the PAGE and SEC analyses. These findings help to build upon Lexaria’s growing dataset ...

Share on Pinterest A new study found a link between semaglutide use and suicidal ideation, adding to an ongoing debate over the safety of GLP-1 drugs. Halfpoint Images/Getty Images The authors of ...

A new observational study ... other drugs, though experts raised concerns about the methodology and the findings contradict what some other studies have found about the class of GLP-1 diabetes ...

Aspen Pharmacare fell short of its targeted mid-single digit growth in core profit on Tuesday, but is betting on GLP-1 drug ...